Company: RPID
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0001380106-25-000089
Chunk: 30

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 30
---
 Board and (ii) all meetings of the committees on which the director served during the period in which he or she served as a director. Under our Corporate Governance Guidelines, which are available on our website at investors.rapidmicrobio.com, a director is expected to spend the time and effort necessary to properly discharge his or her responsibilities. Accordingly, a director is expected to regularly prepare for and attend meetings of the Board and all committees on which the director sits (including separate meetings of the independent directors), with the understanding that, on occasion, a director may be unable to attend a meeting. A director who is unable to attend a meeting of the Board or a committee of the Board is expected to notify the Chair of the Board or the Chair of the appropriate committee in advance of such meeting, and, whenever possible, participate in such meeting via teleconference in the case of an in-person meeting. We do not maintain a formal policy regarding director attendance at the Annual Meeting; however, it is expected that, absent compelling circumstances, directors will attend. In 2024, Mses. Litherland and Lowenstein, Dr. Malloy, and Messrs. Ricciardi, Schwartz and Spignesi attended the Annual Meeting of Stockholders. COMMITTEES OF THE BOARD Our Board has established three standing committees—Audit, Compensation, and Nominating and Corporate Governance—each of which operates under a written charter that has been approved by our Board. The members of each of the Board committees are set forth in the following chart.

| Name                  |     | Audit |     | Compensation |     | Nominating and       
 Corporate Governance |
| Richard Kollender     |     | X     |     |              |     | X                    |
| Melinda Litherland    |     | Chair |     |              |     |                      |
| Inese Lowenstein      |     | X     |     | X            |     |                      |
| Kirk D. Malloy, Ph.D. |     |       |     | Chair        |     |                      |
| Natale Ricciardi      |     |       |     | X            |     | X                    |
| Jeffrey Schwartz      |     |       |     |              |     | Chair                |
| Robert Spignesi       |     |       |     |              |     |                      |

AUDIT COMMITTEE The Audit Committee’s responsibilities include, among other things: • appointing, approving the compensation of, and assessing the independence of our registered public accounting firm; •